You searched for "scarring"

2274 results found

Mono vs. multi-therapy in IOP control

This randomised control trial studied newly diagnosed glaucoma patients given mono‐ or multi‐therapy regarding differences in initial intraocular pressure (IOP) reduction, target IOP levels reached and influence of untreated baseline IOP on IOP reduction. Patients newly diagnosed with manifest primary...

Impact of COVID-19 on primary retinal detachments

This study aimed to describe the impact of the COVID-19 pandemic on the presentation characteristics, timings, and surgical decisions for primary rhegmatogenous retinal detachment (RRD). The cohort included all patients who presented to a Portuguese centre over a two-year period,...

Changes in ocular biomarkers in Vogt-Koyanagi-Harada disease after pulse steroid therapy

This retrospective study aimed to evaluate the early and chronological changes in ocular biomarkers in patients of Vogt Koyanagi Harada (VKH) disease who received pulse steroid therapy. It further aimed to identify which biomarkers correlated with the best corrected visual...

There will be a 27% rise in the number of people living with sight loss in the UK by 2035, RNIB the UK’s leading sight loss charity predicts

This World Sight Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) was calling for the UK Government to prioritise eye health. This is after fresh insight from the charity that shows there will be a...

Emerging developments in dry eye

An estimated 344 million people worldwide suffer from dry eye [1]. This chronic syndrome is characterised by a vicious cycle of tear film hyperosmolarity, tear instability and corneal stress, leading to increased friction, inflammation, ocular surface damage and decreased visual...

Cataract incidence rates in patients from the UK suffering with diabetes mellitus

The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...

Specsavers Launches brand new Roblox Obby

Specsavers has unveiled the ‘Specsavers Obby’, a new branded obstacle course game and virtual merchandise giveaway on Roblox, marking the high-street retailer’s commitment to educating younger generations and continued steps into the gaming space.

Moorfields Eye Charity’s six-year growth and impact

Moorfields Eye Charity launches its impact report showing that it has grown to become the leading charity in the UK funding research into eye health and innovation and improvement in patient care.

It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?

Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...

Consistency in comfort: discussion workshop in collaboration with Johnson & Johnson Vision- July

About the event This interactive, fast-paced discussion workshop will help delegates explore what comfort means in contact lenses and how we can retain patients in contact lenses, through studies, patient cases and videos. The workshop will equip delegates with the...

Consistency in comfort: discussion workshop in collaboration with Johnson & Johnson Vision September

About the event This interactive, fast-paced discussion workshop will help delegates explore what comfort means in contact lenses and how we can retain patients in contact lenses, through studies, patient cases and videos. The workshop will equip delegates with the...

2030 In Sight: Ending avoidable sight loss

Over 2.2 billion people on our planet live with visual impairment or blindness with 1.1 billion unable to access affordable treatment. The 2030 In Sight sector strategy led by the International Agency for the Prevention of Blindness (IAPB) is an...